Clinical Trial Update: A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL [Phase 2]

View source ↗

Summary

Phase 2 study updating on the treatment-sparing effects of AEROVANT AER 001 inhalation powder in asthma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AEROVANT AER 001 Inhalation Powder

Snippet

Sponsor: Aerovance, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED